Chronic GVHD in minor salivary glands and oral mucosa: Histopathological and immunohistochemical evaluation of 25 patients

Journal of Oral Pathology and Medicine

Volumn 34, Issue 6, 2005, Pages 368-373

  Soares, Andresa Borges ^a   Faria, P R ^a   Magna, L A ^a   Correa, M E P ^a   De Sousa, C A ^a   Almeida, O P ^a   Cintra, M L ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Bone marrow transplantation; CD20; CD4; CD45; CD68; CD8; Oral mucosa; Pathology; Salivary gland

Indexed keywords

CD20 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MINOR SALIVA GLAND; MOUTH MUCOSA; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD20; ANTIGENS, CD4; ANTIGENS, CD45; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; CONNECTIVE TISSUE; EPITHELIUM; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LYMPHOCYTES; MACROPHAGES; MALE; MIDDLE AGED; MOUTH DISEASES; MOUTH MUCOSA; RETROSPECTIVE STUDIES; SALIVARY GLAND DISEASES; SALIVARY GLANDS, MINOR;

EID: 20944436323     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2005.00322.x     Document Type: Article

References (29)

1. Woo SB, Lee JS, Schubert MM. Graft-vs-host disease. Crit Rev Oral Biol Med 1997; 8: 201-16.
2. Hasseus B, Jontell M, Brune M, Johansson P, Dahlgren UI. Langerhans cells and T cells in oral graft versus host disease and oral lichen planus. Scand J Immunol 2001; 54: 516-24.
3. Sullivan KM. Acute and chronic graft-versus-host disease in man. Int J Cell Cloning 1986; 4: 42-93S1.
4. Aractingi S, Chosidow O. Cutaneous graft-versus-host disease. Arch Dermatol 1998; 134: 602-12.
5. Nakamura S, Hiroki A, Shinohara M, et al. Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 556-63.
6. Curtis JW Jr, Caughman GB. An apparent unusual relationship between rampant caries and the oral mucosal manifestations of chronic graft-versus-host disease. Oral Surg Oral Med Oral Pathol 1994; 78: 267-72.
7. Sale GE, Shulman HM, Schubert MM, et al. Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy. Hum Pathol 1981; 12: 1022-30.
8. Schubert MM, Sullivan KM. Recognition, incidence, and management of oral graft-versus-host disease. NCI Monogr 1990; 9: 135-43.
9. Loughran Jr TP, Sullivan K, Morton T, et al. Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Blood 1990; 1: 228-34.
10. Nicolatou-Galitis D, Kitra V, Van-Vliet-Constantinidou C, et al. The oral manifestations of chronic graft-versus-host disease (cGVHD) in paediatric allogeneic bone marrow transplant recipients. J Oral Pathol Med 2001; 30: 148-53.
11. Hiroki A, Nakamura S, Shinohara M, Oka M. Significance of oral examination in chronic graft-versus-host disease. J Oral Pathol Med 1994; 23: 209-15.
12. Stansfeld AG, Diebold J, Kapanci Y, et al. Updated Kiel classification for lymphomas. Lancet 1988; I: 292-3.
13. Bains RM, Miller KD. Peroxidase labelling in immunocytochemistry: a critical comparison of five systems. Med Lab Sci 1988; 45: 240-4.
14. Cabeçadas JM, Isaacson PG. Phenotyping of T-cell lymphomas in paraffin sections - which antibodies? Histopathology 1991; 19: 419-24.
15. Kurtin PJ, Roche PC. Immunoperoxidase staining of non-Hodgkin's lymphomas for T-cell lineage associated antigens in paraffin sections. Comparison of the performance characteristics of four commercially available antibody preparations. Am J Surg Pathol 1993; 17: 898-904.
16. Mason DY, Cocdell JL, Gaulard P, Tse AGD, Brown MH. Immunohistological delection of human cytotoxic/suppressor T cells using antibodies to a CD8 peptide sequence. J Clin Pathol 1992; 45: 1084-8.
17. Gocke CD. Non-Hodgkin's lymphoma. In: Dabbs DJ, ed. Diagnostic immunohistochemistry. Philadelphia, MA: Churchill Livingstone, 2002; 115.
18. Falini B, Flenghi L, Pileri S, et al. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 1993; 142: 1359-72.
19. Torlakovic E, Torlakovic G, Nguyen PL, Brunning RD, Delabie J. The value of anti-PAX 5 immunostaining inroutinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker. Am J Surg Pathol 2002; 26: 1343-50.
20. Quinlanilla-Martinez L, Preffer F, Rubin D, Ferry JA, Harris NL. CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset. Am J Clin Pathol 1994; 102: 483-9.
21. Nakhleh RE, Miller W, Snover CD. Significance of mucosal vs salivary gland changes in lip biopsies in the diagnosis of chronic graft-vs-host disease. Arch Pathol Lab Med 1989; 113: 932-4.
22. Horn TD, Rest EB, Mirenski Y, Corio RL, Zahurak ML, Vogelsang GB. The significance of oral mucosal and salivary gland pathology after allogeneic bone marrow transplantation. Arch Dermatol 1995; 131: 964-5.
23. Cooke KR, Ferrara JLM. A protective gene for graft-versus-host disease. N Engl J Med 2003; 349: 2183-4.
24. Nagler RM, Nagler A. The molecular basis of salivary gland involvement in graft-vs-host disease. J Dent Res 2004; 83: 98-103.
25. Lombardi T, Hauser C, Budtz-Jörgensen E. Langerhans cells: structure, function and role in oral pathological conditions. J Oral Pathol Med 1993; 22: 193-202.
26. Mattsson T, Sundqvist KG, Heimdahl A, Dahllöf G, Ljungman P, Ringden O. A comparative immunological analysis of the oral mucosa in chronic graft-versus-host disease and oral lichen planus. Arch Oral Biol 1992; 37: 539-47.
27. Ichiba T, Teshima T, Kuick R, et al. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood 2003; 102: 763-71.
28. Korngold R, Sprent J. T-cell subsets in graft-vs-host disease. In: Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K, eds. Graft-vs-host disease: immunology, pathophysiology, and treatment. New York: Marcel Dekker, 1990; 317-25.
29. Teshima T, Hill GR, Pan L, et al. Il-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. J Clin Invest 1999; 104: 317-25.